CJ
VRTX icon

Caitlin John’s Vertex Pharmaceuticals VRTX Stock Holding History

Caitlin John’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.4K Hold
31
– – 0.01% 539
2026
Q1 		$13.8K Hold
31
– – 0.01% 479
2025
Q4 		$14.1K Hold
31
– – 0.01% 487
2025
Q3 		$12.1K Buy
+31
New +$13K 0.01% 469
2025
Q1 		– Sell
-31
Closed -$12.5K – 788
2024
Q4 		$12.5K Hold
31
– – 0.01% 443
2024
Q3 		$15.3K Hold
31
– – 0.01% 421
2024
Q2 		$14.5K Hold
31
– – 0.01% 398
2024
Q1 		$13K Hold
31
– – 0.01% 416
2023
Q4 		$12.6K Buy
+31
New +$11.5K 0.01% 402

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Caitlin John's VRTX Position: Q2 2026 in Review

Caitlin John held its Vertex Pharmaceuticals (VRTX) position steady in Q2 2026 at 31 shares worth $15.4K. The position accounts for 0.01% of the portfolio, ranked #539.

Caitlin John first reported a position in VRTX in Q4 2023 and has held it in 9 quarters since. 1,757 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Caitlin John held 31 shares of Vertex Pharmaceuticals worth $15.4K as of Q2 2026.
  • Caitlin John left its Vertex Pharmaceuticals share count unchanged in Q2 2026.
  • Vertex Pharmaceuticals made up 0.01% of Caitlin John's portfolio in Q2 2026, its #539 holding.
  • Caitlin John first reported a position in Vertex Pharmaceuticals in Q4 2023 and has held it in 9 quarters since.
  • 1,757 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Caitlin John's 13F filing for Q2 2026, filed 17 Aug 2026.